OptimizeRx OPRX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is OptimizeRx's investing cash flow?
- OptimizeRx (OPRX) reported investing cash flow of -$21K in Q1 2026.
- How has OptimizeRx's investing cash flow changed year-over-year?
- OptimizeRx's investing cash flow increased by 75.0% year-over-year, from -$84K to -$21K.
- What is the long-term trend for OptimizeRx's investing cash flow?
- Over 4 years (2021 to 2025), OptimizeRx's investing cash flow has grown at a -38.8% compound annual growth rate (CAGR), from -$486K to $68K.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.